Search

everythinglearnresearchcommunity

for

Search:↓

Early baldness increases prostate cancer risk, radiotherapy and surgery have similar second cancer rates, and ALA may reduce prostate cancer risk.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Cancer cells often have more copies of TERT and TERC genes, which helps them grow and could affect patient outcomes.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

FDG PET/CT scans can change cancer treatment plans for dogs.

Low testosterone does not prevent prostate cancer in men with type 1 diabetes.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Using a single PSA level to decide on a prostate biopsy is not effective; a more personalized approach considering various factors is recommended.

WNT10A helps esophageal cancer cells spread and keep renewing themselves.

HPV vaccines are generally safe but need further investigation for rare side effects.

There is no standard treatment for the rare Cronkhite–Canada syndrome, which can be fatal and lead to cancer.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.

Histone demethylases play a key role in the development of many diseases and may be targets for treatment.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

High LGR5 levels in glioblastoma indicate poor prognosis and are essential for cancer stem cell survival.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

High-dose finasteride may help treat glioblastoma but needs localized delivery for effectiveness.

Women with aging signs and heart issues have higher hair loss risk, which may predict shorter lifespan and affect attractiveness.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.

Effective treatments for male pattern baldness include oral finasteride and topical minoxidil, while topical minoxidil is best for female pattern baldness.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Using 5-alpha-reductase inhibitors may improve bladder cancer survival in men.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

TGF-β is crucial for controlling stem cell behavior and changes in its signaling can lead to diseases like cancer.